You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Compared with RT-PCR testing, Abbott's BinaxNow test had a sensitivity of 64 percent for samples from symptomatic people and nearly 36 percent for asymptomatic people.
The Maverick instrument enables calibration-free multiplex testing in the field and is supported by cloud-based software.
The organization intends to deploy a prototype of the platform in Brussels Airport next summer.
The PCR test is the first offering from the firm, formerly known as Concepta, since it acquired Manchester-based startup The Genome Store in November.
Called the COVID Bubble Test, the UK-based service allows the testing of up to 10 people on a single cartridge for £100, or £10 per person.
The assay can be used to pool up to five specimens collected from individuals suspected of having COVID-19 or from asymptomatic patients.
The firms had planned to develop the assay on Biocartis' Idylla platform, which would have allowed customers to perform the assay locally in their own lab facilities.
Qiagen said that growth in the quarter was primarily driven by COVID-19 testing products and improving customer demand for other products.
Avapritinib is sold by Blueprint Medicines as Ayvakit for the treatment of adults with unresectable or metastatic GIST harboring a PDGFRA exon 18 mutation.
The effort, called INNO4COV-19, was awarded €6.1 million last month to support the commercialization of new diagnostics.